Related Experiment Videos
Eleven years experience with the Medtronic Hall Valve
I Ayala1, P I Altieri, E Defendini
1Department of Medicine and Surgery, University of Puerto Rico.
Boletin De La Asociacion Medica De Puerto Rico
|May 4, 1999
Summary
This study reports eleven years of experience with the Medtronic Hall Valve in 422 patients. The overall mortality rate observed was 7.9% for this mechanical heart valve replacement.
Area of Science:
- Cardiac Surgery
- Biomaterials in Medicine
- Prosthetic Heart Valves
Background:
- Mechanical heart valves are crucial for treating valvular heart disease.
- Long-term outcomes of prosthetic valves require continuous evaluation.
- The Medtronic Hall Valve is a specific type of mechanical prosthesis.
Purpose of the Study:
- To present an eleven-year clinical experience with the Medtronic Hall Valve.
- To assess the outcomes, including mortality, associated with this valve prosthesis.
Main Methods:
- Retrospective analysis of patient data.
- Inclusion of all patients who received the Medtronic Hall Valve over an eleven-year period.
- Documentation of patient demographics and perioperative/postoperative outcomes.
Main Results:
- A total of 422 patients received the Medtronic Hall Valve.
- The overall observed mortality rate in this cohort was 7.9%.
Conclusions:
- The Medtronic Hall Valve demonstrated a specific mortality profile over an eleven-year period.
- This data contributes to the long-term understanding of mechanical heart valve performance.
- Further analysis may be warranted to explore factors influencing outcomes.